Bemnifosbuvir
CAS No. 1998705-64-8
Bemnifosbuvir ( AT-511 )
Catalog No. M28614 CAS No. 1998705-64-8
Bemnifosbuvir is a novel phosphoramidate prodrug of 2'-fluoro-2'-C-methylguanosine-5'-monophosphate that has potent in vitro activity against HCV.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 224 | In Stock |
|
10MG | 374 | In Stock |
|
25MG | 623 | In Stock |
|
50MG | 887 | In Stock |
|
100MG | 1197 | In Stock |
|
200MG | Get Quote | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameBemnifosbuvir
-
NoteResearch use only, not for human use.
-
Brief DescriptionBemnifosbuvir is a novel phosphoramidate prodrug of 2'-fluoro-2'-C-methylguanosine-5'-monophosphate that has potent in vitro activity against HCV.
-
DescriptionBemnifosbuvir is a novel phosphoramidate prodrug of 2'-fluoro-2'-C-methylguanosine-5'-monophosphate that has potent in vitro activity against HCV.(In Vitro):AT-511 is a novel phosphoramidate prodrug of 2'-fluoro-2'-C-methylguanosine-5'-monophosphate that has potent in vitro activity against HCV.In the absence of cells, AT-511 was stable when incubated in culture medium at 37°C for up to 24 h. AT-9010 was the predominant intracellular metabolite measured in all hepatocyte species and Huh-7 cell incubations with 10 μM AT-511 and, except in mouse hepatocytes,far exceeded intracellular AT-511 concentrations,demonstrating that the active TP was efficiently formed from its phosphoramidate protide in liver cells. In hepatocyte incubations, the relative levels of AT-9010 formed, and its accumulation over 24 h expressed as area under the curve or AUC0-24h; from most to least abundant, were rat>human >mouse >dog/monkey.(In Vivo):Treatment with moxifloxacin every 8?hr was accompanied by longer survival than in any other group.Tissue cultures 30?hr after bacterial challenge showed considerably less bacterial growth in the spleens and lungs of moxifloxacin-treated animals than in the other groups, but not in their livers.
-
SynonymsAT-511
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1998705-64-8
-
Formula Weight581.5
-
Molecular FormulaC24H33FN7O7P
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCC(OC([C@@H](N[P@](OC[C@@H]1[C@H]([C@](C)([C@](N2C=NC3=C(N=C(N=C32)N)NC)(O1)[H])F)O)(OC4=CC=CC=C4)=O)C)=O)C
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Kishii R, et al. In Vitro Activities and Spectrum of the Novel Fluoroquinolone Lascufloxacin (KRP-AM1977). Antimicrob Agents Chemother. 2017 May 24;61(6). pii: e00120-17.
molnova catalog
related products
-
GW604714X?
GW604714X were found to be potent inhibitors of mitochondrial respiration supported by pyruvate.
-
Cassiaside B2
Cassiaside B2 is an inhibitor of protein tyrosine phosphatase 1B (PTP1B) and human monoamine oxidase A (hMAO-A).Cassiaside B2 is an agonist of the 5-HT2C receptor with anti-allergic activity.Cassiaside B2 is one of the active ingredients in the naphthylpyrone reference extract (NRE).
-
Valpramide
Valpromide is a carboxamide derivative of valproic acid used in the treatment of epilepsy and some affective disorders.